Detalhe da pesquisa
1.
Determinants of drug-resistant tuberculosis in Hunan province, China: a case-control study.
BMC Infect Dis
; 24(1): 198, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350860
2.
Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China.
BMC Infect Dis
; 24(1): 159, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308252
3.
A caprylate esterase-activated fluorescent probe for sensitive and selective detection of Salmonella enteritidis.
Anal Bioanal Chem
; 415(12): 2163-2172, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869898
4.
Risk factors associated with unsuccessful tuberculosis treatment outcomes in Hunan Province, China.
Trop Med Int Health
; 27(3): 290-299, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014123
5.
The impact of ethnic minority status on tuberculosis diagnosis and treatment delays in Hunan Province, China.
BMC Infect Dis
; 22(1): 90, 2022 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081919
6.
Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
BMC Infect Dis
; 17(1): 573, 2017 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28814276
7.
Annual risk of tuberculosis infection in rural China: a population-based prospective study.
Eur Respir J
; 48(1): 168-78, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27230438
8.
Whole-Genome Sequencing and Epidemiological Investigation of Tuberculosis Outbreaks in High Schools in Hunan, China.
Infect Drug Resist
; 15: 5149-5160, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082241
9.
Spatial clustering of drug-resistant tuberculosis in Hunan province, China: an ecological study.
BMJ Open
; 11(4): e043685, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33795303
10.
Spatiotemporal Patterns of Tuberculosis in Hunan Province, China.
Int J Environ Res Public Health
; 18(13)2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34202504
11.
Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis.
PLoS One
; 15(1): e0227100, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31899769
12.
Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis.
PLoS One
; 13(5): e0197880, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29791488
13.
Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China.
PLoS One
; 12(1): e0170718, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28114320
14.
Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study.
Lancet Infect Dis
; 17(10): 1053-1061, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28716677
15.
Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study.
Lancet Infect Dis
; 15(3): 310-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25681063